Delivery Order SPE2DB22D3301-SPE2DB25FX9KN
Award Date
1/31/25
Potential Completion Date
2/3/25
Potential Value
$7.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of REMIFENTANIL 1 MG VIALS to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,317.05 and is a Firm Fixed Price Delivery Order with an ultimate completion date of October 28, 2024. This contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award is for the delivery of Remifentanil 1 mg vials to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,622.10 and is a delivery order with a firm fixed price pricing type. The contract runs through December 23, 2024 and was awarded on December 20, 2024. The place of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,667.30, is for the delivery of REMIFENTANIL 1 MG VIALS, a specialty medication. It is a firm fixed-price delivery order contract with a completion date of December 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $11,001.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a completion date of December 31, 2024, is for the delivery of REMIFENTANIL 1 MG VIALS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,236.17, is for the delivery of REMIFENTANIL 1 MG VIALS, a specialty medication. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC serves as...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Remifentanil 2 mg vials. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a ceiling value of $4,539.29. The contract is a delivery order with a firm fixed price pricing type, and the ultimate completion date is January 30, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of REMIFENTANIL 1 MG VIALS. The $2,686.05 firm-fixed-price delivery order has a completion date of December 6, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award is for the delivery of Remifentanil 1 mg vials to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a firm fixed-price delivery order with a ceiling value of $2,121.60 and an ultimate completion date of January 18, 2023. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $3,640.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Remifentanil 2 mg vials, a specialized medication. This award is a delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of REMIFENTANIL 1 MG VIALS. The delivery order contract, valued at $5,149.43, has a firm fixed price and is set to expire on October 22, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth...